Company
Anthogyr
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
6
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
14,534
Received Nov 1, 2025 to Nov 19, 2026
Recall records
2
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Anthogyr, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Anthogyr.
Latest FDA decisions
K231072 · Decided Jan 4, 2024 · 265 days after receipt
Device type: Abutment, Implant, Dental, Endosseous (NHA) · Dentistry & Oral Surgery
K233264 · Decided Dec 22, 2023 · 84 days after receipt
Device type: Sterilization Wrap Containers, Trays, Cassettes & Other Accessories (KCT) · Hospital Medicine & Nursing
K230104 · Decided Oct 16, 2023 · 276 days after receipt
Device type: Implant, Endosseous, Root-Form (DZE) · Dentistry & Oral Surgery
3 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Tissue Level vs Bone Level Implants for Plural Restorations : a Multicentre Randomised Controlled TrialActive, not recruiting
NCT05223387 · 40 participants · Start Mar 30, 2022 · Primary completion Jul 18, 2025
Device: Axiom TL REG; Axiom BL REG · For: Dental Implants; Edentulous
Sites: Porto, Portugal; Barcelona, Spain; Santiago de Compostela, Spain
- Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 ImplantsActive, not recruiting
NCT05768295 · 200 participants (planned) · Start Apr 5, 2023 · Primary completion Aug 20, 2025
Device: Axiom BL X3 · For: Surgical Operation; Edentulous Jaw; Edentulous Mouth and 1 more
Sites: Annecy, France; Beauvais, France; Cadaujac, France · 13 sites in all
Reports received
14,534
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
0.0% of reports
Injury reports
14,534
100% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 963 | 0 | 0 |
| Jan 24 | 0 | 1,001 | 0 | 0 |
| Feb 24 | 0 | 853 | 0 | 0 |
| Mar 24 | 0 | 787 | 0 | 0 |
| Apr 24 | 0 | 810 | 0 | 0 |
| May 24 | 0 | 902 | 0 | 0 |
| Jun 24 | 0 | 710 | 0 | 0 |
| Jul 24 | 0 | 673 | 0 | 0 |
| Aug 24 | 0 | 771 | 0 | 0 |
| Sep 24 | 0 | 857 | 0 | 0 |
| Oct 24 | 0 | 734 | 0 | 0 |
| Nov 24 | 0 | 683 | 0 | 0 |
| Dec 24 | 0 | 941 | 0 | 0 |
| Jan 25 | 0 | 598 | 0 | 0 |
| Feb 25 | 0 | 701 | 0 | 0 |
| Mar 25 | 0 | 1,116 | 0 | 0 |
| Apr 25 | 0 | 530 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 3,216 | 0 | 0 |
| Jul 25 | 0 | 968 | 0 | 0 |
| Aug 25 | 0 | 1,267 | 0 | 0 |
| Sep 25 | 0 | 1,345 | 0 | 0 |
| Oct 25 | 0 | 1,052 | 0 | 0 |
| Nov 25 | 0 | 1,240 | 0 | 0 |
| Dec 25 | 0 | 1,401 | 0 | 0 |
| Jan 26 | 0 | 1,183 | 0 | 0 |
| Feb 26 | 0 | 1,031 | 0 | 0 |
| Mar 26 | 0 | 1,401 | 0 | 0 |
| Apr 26 | 0 | 1,202 | 0 | 0 |
| May 26 | 0 | 988 | 0 | 0 |
| Jun 26 | 0 | 1,212 | 0 | 0 |
| Jul 26 | 0 | 1,349 | 0 | 0 |
| Aug 26 | 0 | 1,328 | 0 | 0 |
| Sep 26 | 0 | 1,175 | 0 | 0 |
| Oct 26 | 0 | 1,024 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2753-2016 · Started Jun 20, 2016 · Posted by FDA Sep 8, 2016
Reason given: Following a FDA inspection showing that the firm failed to validate the design and process of its implants.
Cause as FDA categorized it: Device Design · Device type: Implant, Endosseous, Root-Form (DZE)
Z-2754-2016 · Started Jun 20, 2016 · Posted by FDA Sep 8, 2016
Reason given: Following a FDA inspection showing that the firm failed to validate the design and process of its implants.
Cause as FDA categorized it: Device Design · Device type: Implant, Endosseous, Root-Form (DZE)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.